Back to Results

A Phase 2a, Multicenter, Randomized, Patient and Evaluator Blinded, Controlled Study Evaluating the Safety and Efficacy of NTX-001 Compared to Standard of Care in the Treatment of Acute Single Transected Peripheral Nerve Injury Occurring below the Distal Border of the Brachial Plexus Requiring Surgical Repair

Study

Is this Study for You?

Let's Get Started!

Description

NTX-001 is a single use surgical product intended for use in conjunction with standard suture neurorrhaphy of a severed nerves in patients between 16 and 65 years of age.

Details
Age

Child to Adult

Eligibility

16 - 65 yo; single transected peripheral nerve injury; surgery will take place within 48 hrs of injury

Phase

II - Research Studies that gather preliminary data on whether a drug works in people who have a certain condition/disease (that is, the drug's effectiveness). For example, participants receiving the drug may be compared to similar participants receiving a different treatment, usually an inactive substance (called a placebo) or a different drug. Safety continues to be evaluated, and short-term adverse events are studied.

Type of Study

Treatment

Locations

Denver Health and Hospital Authority
University of Colorado Hospital

Principal Investigator
Kevin Lillehei

Kevin Lillehei

Study ID

Protocol Number: 20-1997

More information available at ClinicalTrials.gov: NCT04572906

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers